Belvedere Trading
BSX icon

Belvedere Trading’s Boston Scientific BSX Stock Holding History

Belvedere Trading’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-29,880
Closed -$396K – 61
2014
Q4 		$396K Buy
+29,880
New +$382K ﹤0.01% 273

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Belvedere Trading's BSX Position: Q1 2015 in Review

Belvedere Trading sold out of Boston Scientific (BSX) in Q1 2015, closing a stake of 29,880 shares — an estimated $396K sold.

Belvedere Trading first reported a position in BSX in Q4 2014 and held it in 1 quarter. The position peaked at $396K in Q4 2014. 469 funds tracked by Wall St. Rank hold BSX as of Q1 2015.

  • Belvedere Trading reported no remaining Boston Scientific position as of Q1 2015 after selling out during the quarter.
  • Belvedere Trading sold 29,880 Boston Scientific shares in Q1 2015, an estimated $396K.
  • Belvedere Trading first reported a position in Boston Scientific in Q4 2014 and held it in 1 quarter.
  • Belvedere Trading's Boston Scientific position peaked at $396K in Q4 2014.
  • 469 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2015.

Based on Belvedere Trading's 13F filing for Q1 2015, filed 14 May 2015.